|
Scleroderma Foundation Representatives Attend
American College of Rheumatology Annual Meeting
Members of the Scleroderma Foundation's national office were
in San Francisco, Calif., last week for the annual meeting of the American
College of Rheumatology (ACR). More than 16,000 rheumatologists, clinical researchers and other professionals from around the
world were at the meeting. The Foundation experienced a large number of
visitors to its booth. During the event, the Foundation announced its upcoming Continuing Medical Education program for physicians and nurses. The new course with be on Difficult Management
Problems in Systemic Sclerosis for physicians and nurses.
ACR is an important venue for the Foundation to strengthen
relationships with physicians, current and potential funding partners,
patient/membership organizations and others. An in-depth article on current
research results, findings, and advances reported at the meeting, be sure to
tune in to our Spring edition of the “Scleroderma Voice”. If you would like to
receive this quarterly magazine, we welcome you to become a member of the Foundation.
|
|
New Study Reveals Promising Treatment for Interstitial Lung Disease
 Lung complications of scleroderma are potentially very serious. One complication is interstitial lung disease, which is characterized by progressive scaring of the lung tissue that eventually hinders a person's ability to breathe. A new two-year study shows mycophenolate motifil to be as effective cyclophosphamide in treating interstitial lung disease.
Click here to see the full press release >>
|
